The current clinical practice of pharmacogenetic testing in Europe: TPMT and HER2 as case studies

被引：57
|
作者：
Woelderink, A
Ibarreta, D
Hopkins, MM
Rodriguez-Cerezo, E
机构：
[1] European Commiss, Joint Res Ctr, IPTS, E-41092 Seville, Spain
[2] Univ Sussex, SPRU Sci & Technol Policy Res, Brighton, E Sussex, England
来源：
PHARMACOGENOMICS JOURNAL | 2006年 / 6卷 / 01期
基金：
英国经济与社会研究理事会;
关键词：
D O I：
10.1038/sj.tpj.6500341
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
[No abstract available]
引用
收藏
页码：3 / 7
页数：5
相关论文
共 50 条
  • [41] HER2 Testing State of the Laboratories
    Mohsin, Syed K.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2010, 134 (05) : 660 - 662
  • [42] Practice of HER2 Testing in Invasive Breast Cancer: A Single Center Experience
    Mani, Malary
    Mannan, Abul Ala Syed Rifat
    Fan, Wen
    MODERN PATHOLOGY, 2017, 30 : 512A - 512A
  • [43] Pharmacogenetic testing in idiosyncratic drug-induced liver injury: current role in clinical practice
    Aithal, Guruprasad P.
    LIVER INTERNATIONAL, 2015, 35 (07) : 1801 - 1808
  • [44] HER2 Testing by FISH: Discordance between HER2 Signals Per Cell and HER2:CEP 17 Ratio
    Dintzis, S. M.
    Allison, K. H.
    Schmidt, R. A.
    CANCER RESEARCH, 2010, 70
  • [45] The management of ER low HER2 negative breast cancer in the United Kingdom: A survey of current clinical practice
    Berner, A. M.
    Sit, K. C.
    Hall, P. E.
    CLINICAL ONCOLOGY, 2025, 38
  • [46] HER2 testing in breast cancer: an overview of current techniques and recent developments
    Pathmanathan, N.
    Bilous, A. Michael
    PATHOLOGY, 2012, 44 (07) : 587 - 595
  • [47] Testing for HER2 in breast cancer: current pathology challenges faced in Canada
    Hanna, W.
    Barnes, P.
    Berendt, R.
    Chang, M.
    Magliocco, A.
    Mulligan, A. M.
    Rees, H.
    Miller, N.
    Elavathil, L.
    Gilks, B.
    Pettigrew, N.
    Pilavdzic, D.
    SenGupta, S.
    CURRENT ONCOLOGY, 2012, 19 (06) : 315 - 323
  • [48] Current status of HER2 testing - Caught between a rock and a hard place
    Schnitt, SJ
    Jacobs, TW
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2001, 116 (06) : 806 - 810
  • [49] HER2 in uterine serous carcinoma: Current state and clinical perspectives
    Sanchez, Janira M. Navarro
    Finkelman, Brian S.
    Turner, Bradley M.
    Katerji, Hani
    Wang, Xi
    Varghese, Sharlin
    Wang, Tiannan
    Peng, Yan
    Hicks, David G.
    Zhang, Huina
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2023, 160 (04) : 341 - 351
  • [50] HER2 testing pattern, characteristics of locally advanced or metastatic NSCLC patients by HER2 testing in France
    Debieuvre, D.
    Macouillard, P.
    Quantin, X.
    Berktas, M.
    Girard, N.
    Valette, C. Audigier
    Filleron, T.
    Musilli, S.
    Bosquet, L.
    Perol, M.
    ANNALS OF ONCOLOGY, 2023, 34
12345